copper sulfate has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, NS; Nathan, CF; Stuehr, DJ | 1 |
| Berners-Price, SJ; Crooke, ST; Faucette, LF; Johnson, RK; Mattern, MR; McCabe, FL; Mirabelli, CK; Mong, SM; Sadler, PJ; Sung, CM | 1 |
2 other study(ies) available for copper sulfate and Leukemia L 1210
| Article | Year |
|---|---|
Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Copper; Copper Sulfate; Ferredoxins; Gas Chromatography-Mass Spectrometry; Hydroxyurea; Interferon-gamma; Kinetics; Leukemia L1210; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Ribonucleotide Reductases | 1991 |
In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Cisplatin; Copper; Copper Sulfate; DNA; Gold; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Nucleic Acids; Organogold Compounds; Organometallic Compounds; Organophosphorus Compounds; Protein Biosynthesis; Sarcoma, Experimental | 1986 |